Nothing Special   »   [go: up one dir, main page]

ATE497764T1 - Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on - Google Patents

Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on

Info

Publication number
ATE497764T1
ATE497764T1 AT02779994T AT02779994T ATE497764T1 AT E497764 T1 ATE497764 T1 AT E497764T1 AT 02779994 T AT02779994 T AT 02779994T AT 02779994 T AT02779994 T AT 02779994T AT E497764 T1 ATE497764 T1 AT E497764T1
Authority
AT
Austria
Prior art keywords
preparation
pyrazolin
phenyl
methyl
percutane
Prior art date
Application number
AT02779994T
Other languages
English (en)
Inventor
Jun Mori
Tamaki Horiuchi
Seijiro Yama
Hitomi Waki
Shingo Shimada
Hitomi Hashitani
Original Assignee
Lead Chem Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Chem Co Ltd filed Critical Lead Chem Co Ltd
Application granted granted Critical
Publication of ATE497764T1 publication Critical patent/ATE497764T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT02779994T 2002-11-05 2002-11-05 Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on ATE497764T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2002/011518 WO2004041270A1 (ja) 2002-11-05 2002-11-05 ３−メチル−１−フェニル−２−ピラゾリン−５−オン含有経皮吸収製剤

Publications (1)

Publication Number Publication Date
ATE497764T1 true ATE497764T1 (de) 2011-02-15

Family

ID=32310225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02779994T ATE497764T1 (de) 2002-11-05 2002-11-05 Perkutane absorptionszubereitungen mit 3-methyl-1-phenyl-2-pyrazolin-5-on

Country Status (10)

Country Link
US (1) US20050266062A1 (de)
EP (1) EP1559426B1 (de)
JP (1) JP4487258B2 (de)
CN (1) CN100372531C (de)
AT (1) ATE497764T1 (de)
AU (1) AU2002344454A1 (de)
CA (1) CA2504873C (de)
DE (1) DE60239165D1 (de)
HK (1) HK1084588A1 (de)
WO (1) WO2004041270A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004307364A (ja) * 2003-04-03 2004-11-04 Yuutoku Yakuhin Kogyo Kk 経皮吸収貼付剤
AU2003280739A1 (en) * 2003-11-12 2004-06-06 Lead Chemical Co., Ltd. Percutaneous absorption type cerebral protective agent
JP2006298774A (ja) * 2005-04-15 2006-11-02 Lead Chemical Co Ltd 経皮吸収型フリーラジカル抑制製剤
CA2610414C (en) * 2005-06-01 2013-09-10 Saitama Daiichi Pharmaceutical Co., Ltd. Skin patch
CN100420726C (zh) * 2005-09-19 2008-09-24 上海安立霸电器有限公司 医用热熔压敏胶型基质及制备
JP4974535B2 (ja) * 2006-02-02 2012-07-11 久光製薬株式会社 外用製剤及びその製造方法
JP5248040B2 (ja) * 2007-05-25 2013-07-31 リードケミカル株式会社 ５−メチル−１−フェニル−２−（１ｈ）−ピリドン含有貼付剤
JPWO2009041714A1 (ja) * 2007-09-26 2011-01-27 三笠製薬株式会社 フリーラジカル性疾患用外用剤
DE102011087317A1 (de) * 2011-11-29 2013-05-29 Henkel Ag & Co. Kgaa Kosmetische Verwendung von 3-Methyl-1-phenyl-5-pyrazolon
JP6444305B2 (ja) * 2013-08-09 2018-12-26 帝國製薬株式会社 ベラプロスト含有貼付剤
US9675537B2 (en) * 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
KR20210065931A (ko) * 2018-09-26 2021-06-04 니찌방 가부시기가이샤 함수계 첩부제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066533B2 (ja) * 1985-09-13 1994-01-26 日東電工株式会社 含水ゲル貼付剤の基剤
JP2512565B2 (ja) * 1989-10-13 1996-07-03 積水化学工業株式会社 貼付剤
JP2569396B2 (ja) * 1992-12-04 1997-01-08 株式会社太平洋 経皮投与型薬物用貼付剤
JPH0912448A (ja) * 1995-04-28 1997-01-14 Read Chem Kk 薬物放出制御型経皮吸収製剤
JP4154621B2 (ja) * 1996-02-07 2008-09-24 リードケミカル株式会社 トラニラスト含有外用製剤及びその製造方法
JPH10120560A (ja) * 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
JPH10265373A (ja) * 1997-03-26 1998-10-06 Lion Corp 粘着剤組成物及びパップ剤
JPH10279480A (ja) * 1997-04-07 1998-10-20 Mitsubishi Chem Corp 皮膚組織障害の予防・治療剤
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体
AU3536799A (en) * 1999-04-26 2000-11-10 Lead Chemical Co., Ltd. Percutaneous preparations containing oxybutynin
JPWO2002000260A1 (ja) * 2000-06-29 2004-01-08 三菱ウェルファーマ株式会社 視神経疾患等治療剤

Also Published As

Publication number Publication date
EP1559426B1 (de) 2011-02-09
CN1694699A (zh) 2005-11-09
HK1084588A1 (en) 2006-08-04
CA2504873A1 (en) 2004-05-21
JPWO2004041270A1 (ja) 2006-03-02
CA2504873C (en) 2011-04-26
US20050266062A1 (en) 2005-12-01
AU2002344454A1 (en) 2004-06-07
DE60239165D1 (de) 2011-03-24
JP4487258B2 (ja) 2010-06-23
CN100372531C (zh) 2008-03-05
WO2004041270A1 (ja) 2004-05-21
EP1559426A4 (de) 2009-03-11
EP1559426A1 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
HK1084588A1 (en) Precutaneous absorption preparations containing 3-methyl-1-phenyl-2-pyrazolin-5-one
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
AU2878689A (en) Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease
EP1201239A4 (de) Cyclische amine als ccr3 antagonisten
DE69635996D1 (de) Pharmazeutische zusammensetzungen mit hydroximsäurederivaten
ATE297730T1 (de) Nasenspray enthaltend ondansetron-hydrochlorid
ATE267191T1 (de) Tricyclische aminderivate
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
EP1374868A4 (de) Mittel zur behandlung und/oder verhütung von diabetischen ischämischen herzerkrankungen
EP1149832A4 (de) Benzamid-derivate und sie enthaltende medikamente
MX9206930A (es) Nuevos compuestos
AU2003256108A1 (en) Organic acid salt of amlodipine
DE60039782D1 (de) Amidinophenylbrenztraubensäure-derivat
EP1685837A4 (de) Gehirnschutzmittel vom perkutanen absorptionstyp
NO20013480L (no) Legemiddel for torr hud
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
DK1144407T3 (da) Cycliske guanidinderivater samt deres anvendelse som pesticider
ATE158503T1 (de) Aids-virus-infektion hemmende zusammensetzung
BR0314567A (pt) N-bromo-2-pirrolidona estável, métodos para prepará-la e seu uso
TH58970B (th) สูตรผสมสำหรับใช้กับตา

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties